3324-0150 Screening compound: (5Z)-3-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]-1,3-thiazolidin-4-one

3324-0150 Screening compound: (5Z)-3-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]-1,3-thiazolidin-4-one
3324-0150 Screening compound: (5Z)-3-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]-1,3-thiazolidin-4-one alternative view

Chemical Structure Depiction of ChemDiv screening compound 3324-0150
(5Z)-3-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]-1,3-thiazolidin-4-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

3324-0150

Molecular Formula

C24H18N2O2S4 (C24 H18 N2 O2 S4)

Compound Name

(5Z)-3-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]-1,3-thiazolidin-4-one

IUPAC name

(5Z)-3-[4-oxo-4-(10H-phenothiazin-10-yl)butyl]-2-sulfanylidene-5-[(thiophen-2-yl)methylidene]-13-thiazolidin-4-one

SMILES

O=C(CCCN(C(/C(/S1)=C/c2cccs2)=O)C1=S)N1c(cccc2)c2Sc2c1cccc2

InChI

InChI=1S/C24H18N2O2S4/c27-22(26-17-8-1-3-10-19(17)31-20-11-4-2-9-18(20)26)12-5-13-25-23(28)21(32-24(25)29)15-16-7-6-14-30-16/h1-4,6-11,14-15H,5,12-13H2

InChI Key

NAORDQKTRIGKPV-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD02216061

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

494.68

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

4

Partition Coefficient, logP

5.064

Distribution Coefficient, logD

5.064

Water Solubility, LogSw

-4.73

Polar Surface Area

30.815

Acid Dissociation Constant (pKa)

21.30

Base Dissociation Constant (pKb)

0.12

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

12.50

3324-0150 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

DGK Inhibitors Library (10558 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Hemic and lymphatic
  • Skin
  • Metabolic
  • Immune system
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with 3324-0150 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 3324-0150?
Check Price and Availability of 3324-0150, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 3324-0150 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 3324-0150
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 3324-0150
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 3324-0150 available by request